0001562180-21-000271.txt : 20210108 0001562180-21-000271.hdr.sgml : 20210108 20210108204846 ACCESSION NUMBER: 0001562180-21-000271 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210106 FILED AS OF DATE: 20210108 DATE AS OF CHANGE: 20210108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Conway Charles CENTRAL INDEX KEY: 0001704256 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38080 FILM NUMBER: 21518883 MAIL ADDRESS: STREET 1: C/O BIOHAVEN PHARMACEUTICAL HOLDING COMP STREET 2: 234 CHURCH STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Biohaven Pharmaceutical Holding Co Ltd. CENTRAL INDEX KEY: 0001689813 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: D8 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 CHURCH STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 BUSINESS PHONE: 203-404-0410 MAIL ADDRESS: STREET 1: 215 CHURCH STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2021-01-06 false 0001689813 Biohaven Pharmaceutical Holding Co Ltd. BHVN 0001704256 Conway Charles C/O BIOHAVEN PHARMACEUTICALS, INC. 215 CHURCH STREET NEW HAVEN CT 06510 false true false false Chief Scientific Officer Common Shares 2021-01-06 4 M false 3750.00 0.00 A 11759.00 D Common Shares 2021-01-06 4 F false 1747.00 83.38 D 10012.00 D Employee Stock Option (right to buy) 83.38 2021-01-06 4 A false 30000.00 0.00 A 2031-01-06 Common Shares 30000.00 30000.00 D Restricted Share Unit Award 2021-01-06 4 A false 15000.00 0.00 A Common Shares 15000.00 15000.00 D Restricted Share Unit Award 2021-01-06 4 M false 3750.00 0.00 D Common Shares 3750.00 11250.00 D This balance includes 731 shares that were acquired through the Biohaven Employee Share Purchase Plan on November 30, 2020. No shares were sold - these shares were withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted share units. The shares underlying this option vest in four equal installments on January 6, 2021, 2022, 2023 and 2024, subject to the reporting person's continuous service with the Issuer at each vesting date. Each restricted share unit represents the contingent right to receive one common share of the Issuer. The reporting person was granted 15,000 restricted share units on January 6, 2021, vesting in four equal installments on January 6, 2021, 2022, 2023 and 2024, subject to the reporting person's continued service with the Issuer at each vesting date. Not applicable. /s/ Jim Engelhart, Attorney-in-Fact 2021-01-08